Ocular Therapeutix Inc (OCUL) — Cash Flow-to-Debt Ratio
Ocular Therapeutix Inc (OCUL) has a Cash Flow-to-Debt Ratio of -0.44x as of March 2026, meaning its operating cash flow of $-65.99 Million could theoretically repay 0% of its total liabilities ($150.96 Million) in one year. See Ocular Therapeutix Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ocular Therapeutix Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Ocular Therapeutix Inc across 14 annual periods. Also explore Ocular Therapeutix Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ocular Therapeutix Inc (2012–2025)
Year-by-year debt coverage analysis for Ocular Therapeutix Inc. For market capitalisation and broader financial context, see Ocular Therapeutix Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.33x | $-204.88 Million | $153.75 Million | ▼ -41.1% |
| 2024 | -0.94x | $-134.68 Million | $142.59 Million | ▼ -116.4% |
| 2023 | -0.44x | $-70.23 Million | $160.93 Million | ▲ +16.6% |
| 2022 | -0.52x | $-59.60 Million | $113.91 Million | ▲ +6.7% |
| 2021 | -0.56x | $-65.55 Million | $116.89 Million | ▼ -94.5% |
| 2020 | -0.29x | $-53.55 Million | $185.77 Million | ▲ +69.4% |
| 2019 | -0.94x | $-77.58 Million | $82.37 Million | ▲ +28.9% |
| 2018 | -1.32x | $-49.23 Million | $37.17 Million | ▲ +23.2% |
| 2017 | -1.72x | $-50.47 Million | $29.28 Million | ▼ -16.2% |
| 2016 | -1.48x | $-34.00 Million | $22.93 Million | ▲ +9.0% |
| 2015 | -1.63x | $-33.74 Million | $20.72 Million | ▼ -54.9% |
| 2014 | -1.05x | $-20.50 Million | $19.50 Million | ▼ -553.6% |
| 2013 | -0.16x | $-12.64 Million | $78.62 Million | ▲ +8.1% |
| 2012 | -0.18x | $-12.59 Million | $71.90 Million | — |